KVISTGAARD, Denmark, May 31, 2013 - Bavarian Nordic A/S announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending the granting of a marketing authorization for IMVANEXA for active immunization against smallpox disease for the general adult population, ... (more)
http://www.pr-inside.com/bavarian-nordic-apos-s-imvanex-smallpox-vaccine-re-r3683094.htm
http://www.pr-inside.com/bavarian-nordic-apos-s-imvanex-smallpox-vaccine-re-r3683094.htm
